News from the FDA/CDC
News from the FDA/CDC
FDA grants emergency authorization for Novavax COVID vaccine
Clinical trials found the vaccine to be 90.4% effective in preventing mild, moderate or severe COVID-19.
FDA/CDC
FDA panel rejects pimavanserin for Alzheimer’s psychosis
The FDA will make its final decision by August 4.
News from the FDA/CDC
FDA authorizes Pfizer’s COVID booster for kids ages 5 to 11
“The omicron wave has seen more kids getting sick with the disease and being hospitalized, and children may also experience longer-term effects,...
News from the FDA/CDC
CDC panel lists reasons to get second COVID booster
One panelist said she was concerned about the potential for “booster fatigue.”
News from the FDA/CDC
FDA to decide by June on future of COVID vaccines
“We’d love to see an annual vaccination similar to influenza but realize that the evolution of the virus will dictate how we respond in terms of...
News from the FDA/CDC
As FDA OKs another COVID booster, some experts question need
“Is the goal to prevent any symptomatic infection with COVID-19, is the goal to prevent the spread of COVID-19, or is the goal to prevent severe...
News from the FDA/CDC
Immunocompromised patients should receive fourth COVID shot: CDC
The CDC contacted pharmacies on Jan. 26 to reinforce the message that people with moderate to severe immune suppression should receive a fourth...
News from the FDA/CDC
CDC to update mask recommendations as Omicron spreads
“The best mask that you wear is the one you will wear and the one you can keep on all day long,” said Dr. Rochelle Walensky.
News from the FDA/CDC
FDA OKs new adult insomnia med
Whereas the overall results are very positive, the improvements in daytime functioning are especially “exciting.”
News from the FDA/CDC
CDC defends new COVID guidance as doctors raise concerns
“The new recommendations on quarantine and isolation are not only confusing, but are risking further spread of the virus.”
News from the FDA/CDC
COVID-19–positive or exposed? What to do next